Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Vogel

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|February 15, 1987
Doxorubicin enhances complement susceptibility of human melanoma cells by extracellular oxygen radical formationR Bredehorst, M Panneerselvam, C W Vogel
Developmental and Comparative Immunology|January 1, 1985
The cobra complement system: I. The alternative pathway of activationC W Vogel, H J Müller-Eberhard
Developmental and Comparative Immunology|January 1, 1985
The cobra complement system: II. The membrane attack complexC W Vogel, H J Müller-Eberhard
Proceedings of the National Academy of Sciences of the United States of America|December 20, 1994
Molecular cloning and derived primary structure of cobra venom factorD C Fritzinger, R Bredehorst, C W Vogel
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1987
Cobra venom factor and human C3 share carbohydrate antigenic determinantsA H Grier, M Schultz, C W Vogel
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1995
Molecular cloning and derived primary structure of cobra venom factorD C Fritzinger, R Bredehorst, C W Vogel
The Journal of Biological Chemistry|September 5, 1988
A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factorM C O'Keefe, L H Caporale, C W Vogel
Haematology and Blood Transfusion|January 1, 1985
In vivo studies with covalent conjugates of cobra venom factor and monoclonal antibodies to human tumorsC W Vogel, S D Wilkie, A C Morgan
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1995
Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3bM W Ollert, K David, R Bredehorst, et al.
Molecular Immunology|March 1, 1992
Structure of the major oligosaccharide of cobra venom factorD C Gowda, M Schultz, R Bredehorst, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|February 15, 1987
Doxorubicin enhances complement susceptibility of human melanoma cells by extracellular oxygen radical formationR Bredehorst, M Panneerselvam, C W Vogel
Developmental and Comparative Immunology|January 1, 1985
The cobra complement system: I. The alternative pathway of activationC W Vogel, H J Müller-Eberhard
Developmental and Comparative Immunology|January 1, 1985
The cobra complement system: II. The membrane attack complexC W Vogel, H J Müller-Eberhard
Proceedings of the National Academy of Sciences of the United States of America|December 20, 1994
Molecular cloning and derived primary structure of cobra venom factorD C Fritzinger, R Bredehorst, C W Vogel
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1987
Cobra venom factor and human C3 share carbohydrate antigenic determinantsA H Grier, M Schultz, C W Vogel
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1995
Molecular cloning and derived primary structure of cobra venom factorD C Fritzinger, R Bredehorst, C W Vogel
The Journal of Biological Chemistry|September 5, 1988
A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factorM C O'Keefe, L H Caporale, C W Vogel
Haematology and Blood Transfusion|January 1, 1985
In vivo studies with covalent conjugates of cobra venom factor and monoclonal antibodies to human tumorsC W Vogel, S D Wilkie, A C Morgan
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1995
Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3bM W Ollert, K David, R Bredehorst, et al.
Molecular Immunology|March 1, 1992
Structure of the major oligosaccharide of cobra venom factorD C Gowda, M Schultz, R Bredehorst, et al.
Pageof 7